Skip to content

An RCT Evaluation of a Diabetes Dashboard Team Model in Primary Care

Case Management for Underserved Hispanic Type 2 Diabetes Populations

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02156037
Enrollment
399
Registered
2014-06-05
Start date
2009-07-31
Completion date
2013-07-31
Last updated
2014-06-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Keywords

Hispanic, clinical decision support, diabetes, Hba1c, psychosocial

Brief summary

To compare a comprehensive diabetes team care condition (IC) involving the diabetes team's use of a diabetes dashboard with a usual diabetes team care condition (UDC) that does not have access to the diabetes dashboard.

Detailed description

To compare a usual diabetes care condition (UDC) to a comprehensive diabetes care intervention condition (IC) involving a diabetes dashboard clinical decision support tool used by the diabetes team in primary care. The investigators used a parallel-groups randomized design. The diabetes team (i.e., diabetes nurses, diabetes dietitians, and providers) delivered a 5-visit, 6-month intervention to n=199 poorly-controlled (HbA1c \>7.5%) Latino T2D patients (mean age=55 years, 60% female) seen at 2 urban community health centers. This intervention was compared to an established, in-house diabetes team care program (n=200) for its impact on blood glucose control and key psychosocial outcomes (diabetes distress, depression, social distress).

Interventions

BEHAVIORALDiabetes Dashboard Intervention

The Diabetes Dashboard Intervention Condition involved a program of five, in-person, one-on-one diabetes education and behavior change visits with a diabetes nurse or diabetes dietician, scheduled at baseline, two weeks, one month, three months, and six months post-enrollment.

The UDC condition was delivered by four bicultural, bilingual diabetes nurses and diabetes dietitians who comprised the clinical site's long-standing, in-house diabetes program.

Sponsors

Baystate Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* age 18 years or older, * self-identified Hispanic ethnicity, * diagnosis of T2D, * HbA1c \>7.5%, and * provider approval given for patient participation

Exclusion criteria

* inability to consent, * pregnant or planning to become pregnant in the next year, * taking glucocorticoid therapy, or * having serious psychiatric or medical complications (e.g., late stage diabetes complications, seizures, dementia, psychiatric hospitalization) that would prevent participation in study activities.

Design outcomes

Primary

MeasureTime frameDescription
HbA1c6 monthsChange in HbA1c over 6 months

Secondary

MeasureTime frameDescription
Diabetes distress6 monthsPatient reported diabetes distress associated with Type 2 diabetes and its treatment measured using the PAID scale
Depression6 monthsPatient-reported depression status based on the PHQ scale

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026